Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than ...

And more than one in ten over the age of 70 would meet the criteria for drugs to slow early stages of the disease.

New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...

ALZHEIMER’S disease is more widespread than previously thought, a first-of-its-kind study suggests. Using a simple blood test ...

The study found more than one in 10 people over the age of 70 would meet the criteria for drugs that can slow down the early ...

Dementia and Alzheimer's are often considered problems of old age, but these are highly influenced by genetic markers. Dr ...

One of the main proteins that contributes to Alzheimer's disease is called phospho-tau (p-tau). When p-tau gets too many ...

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...

New Alzheimer's drug Leqembi offers hope to Oklahoma couple as they celebrate 50 years of marriage and fight against the ...

A daily habit of moving—even a lengthy walk—may slow brain changes that begin decades before Alzheimer’s symptoms emerge.

A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer’s disease. Researchers discovered that LPCs—compounds that transport a variety of healthy ...